Dr. Christian Griñán-Ferré is an Assistant Professor at the University of Barcelona (UB) since 2023 and belongs to the CIBERNED and Institute of Neuroscience of UB. He received a PhD in the epigenetic modulation of Alzheimer’s Disease (AD) at the UB (Awarded a PhD Extraordinary Prize). Prof Griñán-Ferré has focused his research career on aging and Alzheimer’s disease (AD); this leads to drug discovery and target validation to reveal new putative targets and NCEs.  He has a prolific scientific output, including 77 original papers with 1700 citations and an H-index of 23. Several publications are in high-impact journals, such as Br J Pharmacol, Aging Cell, Ageing Res Rev, Geroscience, and Cell Mol Life Sci, and 10 invention patents, 13 PCTs, and 2 patents in exploitation with Neuraly. Thus, he worked actively during the last years on research projects focusing on new drugs that act on new targets to face one of the challenges of current biomedicine: the cognitive deterioration linked to aging and neurodegenerative processes. He has dedicated efforts to studying non-pharmacological (diet, exercise) and pharmacological strategies to ameliorate and to prevent them, with a special focus on drugs acting on new or old targets for cognitive decline (soluble epoxide hydrolase inhibitors, imidazoline I2 receptor ligands, and NMDA antagonists).